These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

900 related articles for article (PubMed ID: 17046193)

  • 1. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
    Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
    Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of estrogen receptor alpha and estrogen receptor beta in gastric cancer.
    Xu CY; Guo JL; Jiang ZN; Xie SD; Shen JG; Shen JY; Wang LB
    Ann Surg Oncol; 2010 Sep; 17(9):2503-9. PubMed ID: 20339947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
    Campbell-Thompson M; Lynch IJ; Bhardwaj B
    Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors.
    Jarzabek K; Koda M; Kozlowski L; Mittre H; Sulkowski S; Kottler ML; Wolczynski S
    Eur J Cancer; 2005 Dec; 41(18):2924-34. PubMed ID: 16289616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and significance of estrogen receptor isoforms in the development of human breast carcinoma].
    Wang S; Wang S; Zhang JQ; Qiao XM; Yang DQ; Tong FZ; Ye YJ; Cui ZR
    Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):792-4. PubMed ID: 15363297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of estrogen receptor beta expression at cancer front correlates with tumor progression and poor prognosis of gallbladder cancer.
    Sumi K; Matsuyama S; Kitajima Y; Miyazaki K
    Oncol Rep; 2004 Nov; 12(5):979-84. PubMed ID: 15492781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer.
    Iwase H; Zhang Z; Omoto Y; Sugiura H; Yamashita H; Toyama T; Iwata H; Kobayashi S
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S34-8. PubMed ID: 12819932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor subtypes in ovarian cancer: a clinical correlation.
    Chan KK; Wei N; Liu SS; Xiao-Yun L; Cheung AN; Ngan HY
    Obstet Gynecol; 2008 Jan; 111(1):144-51. PubMed ID: 18165403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of oestrogen receptor-alpha and oestrogen receptor-beta in prostate cancer.
    Yang GS; Wang Y; Wang P; Chen ZD
    Chin Med J (Engl); 2007 Sep; 120(18):1611-5. PubMed ID: 17908481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
    Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H
    Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study.
    de Giorgi V; Mavilia C; Massi D; Gozzini A; Aragona P; Tanini A; Sestini S; Paglierani M; Boddi V; Brandi ML; Lotti T
    Arch Dermatol; 2009 Jan; 145(1):30-6. PubMed ID: 19153340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
    Zhao ZS; Chu YQ; Ye ZY; Wang YY; Tao HQ
    Hum Pathol; 2010 May; 41(5):686-96. PubMed ID: 20060156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies of the expression of estrogen receptor-alpha and estrogen receptor-beta in prostatic carcinoma].
    Yang GS; Chen ZD
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1111-5. PubMed ID: 15498298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development.
    Park BW; Kim KS; Heo MK; Yang WI; Kim SI; Kim JH; Kim GE; Lee KS
    J Surg Oncol; 2006 May; 93(6):504-10. PubMed ID: 16615154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association between the expression of estrogen receptor subunit in endometrial carcinoma and the prognostic factors of endometrial carcinoma].
    Zhang JW; Peng ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):843-5. PubMed ID: 15573770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas.
    Shaw JA; Udokang K; Mosquera JM; Chauhan H; Jones JL; Walker RA
    J Pathol; 2002 Dec; 198(4):450-7. PubMed ID: 12434414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
    Väisänen MR; Väisänen T; Jukkola-Vuorinen A; Vuopala KS; Desmond R; Selander KS; Vaarala MH
    Prostate; 2010 Jun; 70(8):817-24. PubMed ID: 20054821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.